Undertreatment of cancer patients with chemotherapy is a global concern

Journal of Oncology Practice

Volumn 4, Issue 3, 2008, Pages 114-115

  Lyman, Gary H ^a,b,c  

^a Department of Medicine ^*

^b Health Services and Outcomes Research in Oncology

^c DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGING; BODY SURFACE; BODY WEIGHT; CANCER PATIENT; CLINICAL PRACTICE; CLINICAL TRIAL; DISEASE FREE SURVIVAL; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; ELDERLY CARE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RESEARCH; MEDICAL SOCIETY; NOTE; OBESITY; OVERALL SURVIVAL; PATIENT CARE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; TREATMENT OUTCOME; UNITED STATES; UNSPECIFIED SIDE EFFECT;

EID: 46749102884     PISSN: 15547477     EISSN: None     Source Type: Journal    
DOI: 10.1200/JOP.0831502     Document Type: Note

References (17)

1. Lyman GH: Chemotherapy dose intensity and quality cancer care. Oncology 20:16-25, 2006 (suppl 9)
2. Bonneterre J, Roche H, Kerbrat P, et al: Epirubicin increases long-term survival in adjuvant chemotherapy of patients with poor-prognosis, node-positive, early breast cancer: 10-year follow-up results of the French Adjuvant Study Group 05 randomized trial. J Clin Oncol 20 23:2686-2693, 2005
3. Budman DR, Berry DA, Cirrincione CT, et al: Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer: The Cancer and Leukemia Group B. J Natl Cancer Inst 90:1205-1211, 1998
4. Lepage E, Gisselbrecht C, Haloun C, et al: Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: Application to LNH-87 protocol - The GELA (Groupe d'Etude des Lymphomes de l'Adulte). Ann Oncol 4:651-656, 1993
5. Lyman GH, Dale DC, Crawford J: Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: A nationwide study of community practices. J Clin Oncol 21:4524-4531, 2003
6. Lyman GH, Dale DC, Friedberg J, et al: Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: A nationwide study. J Clin Oncol 22:4302-4311, 2004
7. Balducci L, Hardy CL, Lyman GH: Hemopoiesis and aging. Cancer Treat Res 124:109-134, 2005
8. Shayne M, Culakova E, Poniewierski MS, et al: Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy. Cancer 110: 1611-1620, 2007
9. Smith TJ, Khatcheressian J, Lyman GH, et al: 2006 update of recommendations for the use of white blood cell growth factors: An evidence-based clinical practice guideline. J Clin Oncol 24:3187-3205, 2006
10. Kuderer NM, Dale DC, Crawford J, et al: Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: A systematic review. J Clin Oncol 25: 3158-3167, 2007
11. Rosner GL, Hargis JB, Hollis DR, et al: Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: Results from cancer and leukemia group B study 8541. J Clin Oncol 14:3000-3008, 1996
12. Griggs JJ, Culakova E, Sorbero ME, et al: Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy. J Clin Oncol 25:277-284, 2007
13. Griggs JJ, Sorbero ME, Lyman GH: Undertreatment of obese women receiving breast cancer chemotherapy. Arch Intern Med 165:1267-1273, 2005.
14. Colleoni M, Li S, Gelber RD, et al: Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index. Lancet 366:1108-1110, 2005
15. Sparreboom A, Wolff AC, Mathijssen RH, et al: Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese. J Clin Oncol 25:4707-4713, 2007
16. Field KM, Kosmider S, Jefford M, et al: Chemotherapy dosing strategies in the obese, elderly, and thin patients: Results of a nationwide survey. J Oncol Pract 4:111-116, 2008
17. Malin JL, Schneider EC, Epstein AM, et al: Results of the National Initiative for Cancer Care Quality: How can we improve the quality of cancer care in the United States? J Clin Oncol 24:626-634, 2006